Clinical Trial Update: Effect of RTB101 on Illness Associated With Respiratory Tract Infections in the Elderly [Phase 3]

View source ↗

Summary

Phase 3 trial of RTB101 for illness associated with respiratory tract infections in the elderly has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Tract Infection

Drugs mentioned

• RTB101 (RTB101)

Snippet

Sponsor: Restorbio Inc. | Conditions: Clinically Symptomatic Respiratory Illness | Phase 3 | Status: WITHDRAWN